Summary
Matthew Fuchter is a Professor of Chemistry and co-Director of the Centre for Drug Discovery Science in the Department of Chemistry, Imperial College London. He is also a Founder, NED and Head of Chemistry for NK:IO Ltd. Beyond this, he is a Theme Champion and Management Board member of the Centre for Processable Electronics, an Editorial Board member for the journal Chirality and an Advisory Board member for RSC Medicinal Chemistry (formally MedChemComm). He was formally a member of the Organic Division Council (now Organic Chemistry Community Council) of the Royal Society of Chemistry and the UK representative to the EuCheMS Division of Organic Chemistry. He is involved in multiple multidisciplinary centres of excellence at Imperial including the Institute of Chemical Biology, the Imperial College Network of Excellence in Malaria, the Antimicrobial Research Collaborative, the Centre for Processable Electronics, Centre for Quantum Engineering Science and Technology, and the London Centre for Nanotechnology. He is a Fellow of the Royal Society of Chemistry (since 2015) and the European Academy of Sciences (since 2023).
See his research group website.
Biography
Professor Matthew Fuchter obtained his first class honours degree (MSci in Chemistry) from the University of Bristol in 2002, where he was awarded the Richard N. Dixon prize as well as an undergraduate Scholarship and several faculty commendations. He completed PhD research under the supervision of Professor A. G. M. Barrett, FRS FMedSci and postdoctoral studies at the Commonwealth Scientific and Industrial Research Organisation, Australia, where he worked with Professor A. B. Holmes, AC FRS FAA FInstP. Prior to his position at Imperial College he was the RCUK Academic Fellow at the School of Pharmacy (University of London). He returned to Imperial College in July 2008 as a Lecturer and was promoted to Senior Lecturer in July 2012, Reader in September 2015 and Professor in September 2018.
Professor Fuchter has been awarded a number of prizes in recognition of his work. These include the RSC Harrison-Meldola Memorial Prize (2014), 2nd prize for a Young Medicinal Chemist in Academia (2015), conferred by the European Federation for Medicinal Chemistry (EFMC), a 2017 Imperial College President’s Excellence in Research Award and a President’s Medal (together with Professors Tony Barrett, Charles Coombes and Simak Ali) for Excellence in Innovation and Entrepreneurship, the 2018 Tetrahedron Young Investigator Award for Bioorganic and Medicinal Chemistry, a Blavatnik Award for Young Scientists in the United Kingdom (2020), conferred by the Blavatnik Family Foundation and the New York Academy of Sciences, the RSC Corday-Morgan Prize (2021), a RSC 2022 Materials Chemistry Division Horizon Prize: Stephanie L Kwolek Award, and the 2023 RSC BMCS Malcolm Campbell Memorial Prize.
Publications
Journals
Furlan F, Moreno-Naranjo JM, Gasparini N, et al., 2024, Chiral materials and mechanisms for circularly polarized light-emitting diodes, Nature Photonics, ISSN:1749-4885
Brand MC, Trowell HG, Fuchter MJ, et al., 2024, Incorporating photoresponses into porous liquids, Chemistry: a European Journal, Vol:30, ISSN:0947-6539, Pages:1-7
Shioukhi I, Batchu H, Schwartz G, et al., 2024, Helitwistacenes-combining lateral and longitudinal helicity results in solvent-induced inversion of circularly polarized light, Angewandte Chemie International Edition, Vol:63, ISSN:1433-7851
Constantin TA, Varela-Carver A, Greenland KK, et al., 2024, Correction: The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer., Br J Cancer, Vol:130
Gedeon C, Del Rio N, Furlan F, et al., 2024, Rational design of new conjugated polymers with main chain chirality for efficient optoelectronic devices: carbo[6]helicene and indacenodithiophene copolymers as model compounds, Advanced Materials, ISSN:0935-9648